Search clinical trials for: Innovations in Dementia Empowerment and Action (IDEA)

Total 2137 results

University of Washington
National Institute on Aging (NIA)

Completed

Innovations in Dementia Empowerment and Action (IDEA)

Dementia | Alzheimer Disease | Mild Cognitive Impairment | Vascular Dementia | Lewy Body Dementia | Parkinson Disease Dementia

United States
Chang Gung Memorial Hospital
Chang Gung University of Science and Technology; National Science and Technology...

Not yet recruiting

Construction and Validation of Dementia Care Management Competency

Dementia

Taiwan
Massachusetts General Hospital

Not yet recruiting

The Care for America's Aging Study (CfAA)

Cognitive Impairment | Dementia | Alzheimer Disease | Dementia With Behavioral Disturbance

United States
University of North Carolina, Chapel Hill
National Institute of Nursing Research (NINR)

Completed

Improving Decision Making About Feeding Options for Dementia

Dementia

United States
VA Office of Research and Development
Alzheimer's Association; Benjamin Rose Institute

Completed

Partners in Dementia Care: A Telephone Care Consultation Intervention Provided to Veterans in Partnership With Local Alzheimer's Association Chapters (PDC)

Dementia | Alzheimer Disease

United States
Case Western Reserve University
University of Southern California; AARP Foundation

Active, not recruiting

CONFIDENCE Financial Education for Caregivers (CONFIDENCE)

Dementia | Alzheimer Disease | Caregiver Burden | Financial Stress

United States
Women and Infants Hospital of Rhode Island
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Active, not recruiting

Strength for U in Relationship Empowerment (SURE)

Mental Health | IPV | Perinatal

United States
Hospital Galdakao-Usansolo
Department of Health, Basque Country, Spain

Unknown

Impact of Hospital Admission on Patients With Dementia

Dementia
Hansa Biopharma AB

Recruiting

Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx of Kidneys (ConfIdeSLTFU)

Kidney Transplantation in Highly Sensitized Patients

United States
Mekelle University

Completed

Effect of Community-Based Interventions on Increasing Family Planning Utilization in Pastoralist Community

Family Size

Ethiopia
Kaiser Permanente
University of California, San Diego

Not yet recruiting

Promoting Physical Activity in Older Hispanic/Latino(a) Adults

Sedentary Behavior | Physical Inactivity | Alzheimer Disease, Protection Against

United States
Karolinska Institutet
Karolinska University Hospital; Umeå University; Leiden University; Dalarna University and other collaborators

Recruiting

Development, Implementation and Evaluation of an Individual Decision Aid in Swedish Cancer Screening Programs (BESTa)

Neoplasm, Breast | Neoplasm, Colorectal | Neoplasm, Ovarian

Sweden
Hansa Biopharma AB

Recruiting

A Long-term Follow-up Trial of Patients Previously Treated With Imlifidase Prior to Kidney Transplantation and a Non-comparative Transplanted Patient Group (PAES-LTFU)

Long Term Efficacy and Safety

Spain, Czechia
University of Iowa
Centers for Disease Control and Prevention

Recruiting

Medication Empowerment and Deprescription for Safety (MEDS) Study (MEDS)

Aging | Fall Injury

United States
University of Utah

Completed

Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolus

United States
National Cancer Institute (NCI)

Completed

Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorder

Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Waldenström Macroglobulinemia | Post-transplant Lymphoproliferative Disorder | Stage III Adult Burkitt Lymphoma | Stage III Adult Diffuse Large Cell Lymphoma | Stage IV Adult Burkitt Lymphoma | Stage IV Adult Diffuse...

United States
University of Alabama at Birmingham
National Cancer Institute (NCI); Biogen

Completed

Radioimmunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Lymphoma

United States
San Diego State University
Washington University School of Medicine; University of California, Berkeley; University of California, San Diego

Recruiting

Enhancing Capacity in Churches to Implement PA Programs

Cardiovascular Diseases

United States
Laureate Institute for Brain Research, Inc.
Oklahoma Center for the Advancement of Science and Technology

Completed

Neurocognitive Empowerment for Addiction Treatment (NEAT) in Opioid Use Disorder and Amphetamine Use Disorder (NEAT)

Opioid-use Disorder | Amphetamine Use Disorders

United States
National Cancer Institute (NCI)

Terminated

Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone... and other conditions

United States
National Cancer Institute (NCI)

Terminated

Radiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Lymphoma

Post-transplant Lymphoproliferative Disorder | Recurrent Childhood Large Cell Lymphoma | Recurrent Childhood Lymphoblastic Lymphoma | Recurrent Childhood Small Noncleaved Cell Lymphoma | Recurrent/Refractory Childhood Hodgkin Lymphoma | AIDS-related Peripheral/Systemic Lymphoma | AIDS-related...

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma

Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone Lymphoma | Waldenstrom Macroglobulinemia | Recurrent... and other conditions

United States
IRCCS San Raffaele
Fondazione Telethon

Active, not recruiting

Gene Therapy With Modified Autologous Hematopoietic Stem Cells for the Treatment of Patients With Mucopolysaccharidosis Type I, Hurler Variant (TigetT10_MPSIH)

Mucopolysaccharidosis IH

Italy
Mayo Clinic
National Cancer Institute (NCI)

Completed

Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemia

B-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Stage 0 Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia

United States
Fred Hutchinson Cancer Research Center/University...

Withdrawn

Fludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To Treatment

B-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia
Hip Innovation Technology

Recruiting

Safety and Effectiveness of the HIT Reverse HRS

Osteoarthritis, Hip | Avascular Necrosis of Hip | Degenerative Joint Disease | Traumatic Arthropathy-Hip

United States
Sohag University

Recruiting

Angiotensin Converting Enzyme rs (1799752) Gene Polymorphism and Development of In-Stent Restenosis in Patients With Stable Coronary Artery Diseases in Sohag Hospital University.

Angiotensin Converting Enzyme rs (1799752) Gene Polymorphism and Development of In-Stent Restenosis in Patients With Stable Coronary Artery Diseases

Egypt
Novartis Pharmaceuticals

Completed

Study of Safety and Efficacy of BCL201 and Idelalisib in Patients With FL and MCL

Follicular Lymphoma, Mantle Cell Lymphoma

Austria, France, United States, Germany
University of Arizona
National Cancer Institute (NCI)

Completed

Belinostat and Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Aggressive B-Cell NHL

Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Anaplastic Large Cell Lymphoma

United States
Lee, Stephanie
National Cancer Institute (NCI)

Completed

Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease

Systemic Scleroderma | Graft Versus Host Disease

United States
Meshalkin Research Institute of Pathology of Circulation

Recruiting

Esmolol for Myocardial Protection in Hypertrophic Obstructive Cardiomyopathy

Hypertrophic Obstructive Cardiomyopathy

Russian Federation
Stanford University
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Recruiting

Interventions in Mathematics and Cognitive Skills

Cognitive Dysfunction | Cognitive Change | Learning Disabilities | Individuality | Child Development | Developmental Disability | Behavior | Cognition | Learning Curve | Decision Making | Behavior and Behavior Mechanisms | Behavior, Child | Cognitive Impairment, Mild | Cognition Disorder | Neuroscience | Cognitive Orientation and other conditions

United States
University of East Anglia
University of Hertfordshire; Hertfordshire Sports Partnership; Sport England; Broxbourne... and other collaborators

Unknown

An Evaluation of the Active Herts Physical Activity Programme

Physical Activity

United Kingdom
San Diego State University
National Cancer Institute (NCI)

Completed

Promoting Physical Activity in Churchgoing Latinas

Chronic Disease

United States
Qing XIe
Shanghai MedSci Healthcare Co. Ltd

Unknown

Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis

Hepatocellular Carcinoma | Hepatitis B, Chronic | Compensated Cirrhosis

China
Maastricht University Medical Center

Completed

Location Specific Differences in Intestinal Brake Activation

Obesity | Overweight | Satiety | Overeating | Ileal Brake

Netherlands
Louisiana State University Health Sciences Center...

Recruiting

Field Evaluation of Two Topically Applied Insect Repellent Products Containing IR3535 Against Mosquitos in Louisiana

Bites and Stings

United States
Universidad de Zaragoza

Completed

Effects of Grade III Traction-mobilization in End-range Joint Position in Patients With Hip Osteoarthritis

Osteoarthritis, Hip

Spain
AstraZeneca
KuDOS Pharmaceuticals Limited

Completed

A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of PARP in Combination With Dacarbazine

Melanoma Neoplasms

United States, United Kingdom
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Terminated

High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma

Recurrent Adult Diffuse Large Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Post-Transplant Lymphoproliferative Disorder | Recurrent Burkitt Lymphoma | Refractory Burkitt Lymphoma

United States
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Effect of Low-fat Diet on the Pharmacokinetics of Pyrotinib in Healthy Participants

Healthy Participants
Knopp Biosciences

Completed

Dexpramipexole and Warfarin Drug Drug Interaction (DDI) Study

Healthy Volunteers

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Bortezomib and Gemcitabine in Treating Patients With Relapsed B-Cell Non-Hodgkin Lymphoma

Lymphoma

United States
Dizal Pharmaceuticals

Active, not recruiting

DZD1516 in Combination With Trastuzumab and Capecitabine, or in Combination With T-DM1, in Patients With Metastatic HER2 Positive Breast Cancer

Breast Cancer Metastatic

China, United States
Reviva Pharmaceuticals

Recruiting

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia (RECOVER)

Schizophrenia

United States
Hospices Civils de Lyon

Unknown

Ciclosporin A and Acute Myocardial Infarction

Myocardial Infarction

France
University Hospital, Bordeaux
Novartis; National Cancer Institute, France; Fondation ARC

Recruiting

Spartalizumab and Low-dose PAzopanib in Refractory or Relapsed Solid TumOrs of Pediatric and Adults (SPARTO)

Refractory or Recurrent Solid Tumor

France
National Cancer Institute (NCI)

Completed

Bortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent... and other conditions

United States
National Cancer Institute (NCI)

Withdrawn

Obatoclax Mesylate, Rituximab, and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone Lymphoma

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan

Lymphoma | Leukemia | Graft Versus Host Disease

United States

Search clinical trials for: Innovations in Dementia Empowerment and Action (IDEA)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations